Skip to main content
Clinical Trials/JPRN-UMIN000014798
JPRN-UMIN000014798
Completed
未知

A study on the efficacy of combination therapy of insulin and ipragliflozin in patients with type 2 diabetes - A study on the efficacy of combination therapy of insulin and ipragliflozin in patients with type 2 diabetes

Imamura clinic0 sites15 target enrollmentAugust 8, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Imamura clinic
Enrollment
15
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 8, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Imamura clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Type 1 diabetes 2\) With severe ketosis, diabetic coma, or precoma 3\) With severe infection, pre or post surgery, and serious trauma 4\) Moderate or severe renal dysfunction (Serum Creatinine male: \>\= 1\.5mg/dL, female: \>\= 1\.3mg/dL) 5\) Has stroke, myocardial infarction, or other serious cardiovascular complications requireing hospitalization within 6 months 6\) Is receiving SGLT\-2 inhibitor at initiation 7\) Is nursing or pregnant or planned to become pregnant 8\) With hypersensitivity to ipragliflozin or any other excipient of ipragliflozin 9\) Considered as inadequate by the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials